Related Experiment Video
Updated: Sep 9, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
O-GlcNAcylation: A molecular switch linking brain health to neurodegeneration
Nan Shao1, Xiaoyan Zhang2, Yunzhi Ge1
1College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui Province, China.
Abstract:
Neurodegenerative disorders are typically caused by harmful protein accumulation and nerve cell damage. A post-translational modification called O-linked N-acetylglucosamine ylation acts as a critical regulator in these disorders by controlling protein behavior, cell signaling, and energy balance. This modification is dynamically balanced through the cooperative actions of O-linked N-acetylglucosamine transferase and O-GlcNAcase. In healthy brains, O-GlcNAcylation supports nerve cell function and survival, but its imbalance contributes to disease progression. Notably, the effects of O-GlcNAcylation differ across disorders. This review reveals how O-GlcNAcylation bridges molecular mechanisms to neurodegeneration, as well as the prospects of targeted O-linked N-acetylglucosamine acylation therapy for neurodegenerative diseases. In Alzheimer's disease, it blocks toxic changes in key proteins like tau and amyloid-beta. In Parkinson's disease, it reduces the clumping of alpha-synuclein, yet may disrupt dopamine production. In amyotrophic lateral sclerosis, it protects nerve fiber transport systems. Additionally, O-GlcNAcylation plays an indispensable part in other neurodegenerative conditions, including Huntington's disease, aging, Machado-Joseph disease, multiple sclerosis, and giant axonal neuropathy. New therapies targeting this mechanism include glucosamine supplements and O-GlcNAcase inhibitors, which show clinical promise but face translational challenges.
Insights
O-linked N-acetylglucosamine (O-GlcNAc) modification is crucial for brain health, regulating proteins and cell signaling. Imbalances in O-GlcNAc contribute to neurodegenerative diseases, but targeting this pathway offers therapeutic potential.
Area of Science:
- Biochemistry
- Neuroscience
- Molecular Biology
Background:
- Neurodegenerative disorders stem from protein accumulation and nerve cell damage.
- O-linked N-acetylglucosamine (O-GlcNAc) ylation is a key post-translational modification regulating protein function, cell signaling, and energy balance.
- Dynamic O-GlcNAc balance is maintained by O-linked N-acetylglucosamine transferase and O-GlcNAcase, crucial for neuronal survival.
Purpose of the Study:
- To review the role of O-GlcNAc ylation in neurodegeneration.
- To explore the therapeutic potential of targeting O-GlcNAc ylation in neurological diseases.
- To elucidate how O-GlcNAc ylation impacts various neurodegenerative conditions.
Main Methods:
- Literature review of O-GlcNAc ylation in neurodegenerative disorders.
- Analysis of O-GlcNAc ylation's role in Alzheimer's, Parkinson's, and ALS.
- Examination of O-GlcNAc ylation's involvement in aging and other neurological conditions.
Main Results:
- O-GlcNAc ylation differentially affects protein aggregation and neuronal function across disorders.
- In Alzheimer's, it inhibits toxic protein changes; in Parkinson's, it reduces alpha-synuclein clumps but may affect dopamine.
- It protects nerve fiber transport in ALS and is implicated in Huntington's, aging, and other neurological diseases.
Conclusions:
- O-GlcNAc ylation is a critical molecular link between cellular mechanisms and neurodegeneration.
- Targeted O-GlcNAc ylation therapies, like glucosamine and O-GlcNAcase inhibitors, show promise but require further development.
- Understanding O-GlcNAc ylation dynamics is essential for developing effective treatments for neurodegenerative diseases.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Glial Cells
Protein Glycosylation
Glycosylation occurs in...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Proteoglycans
The Blood-brain Barrier

